Piperacillin/Tazobactam 4.5g IV Vial from Canada
This sterile IV vial contains 4.5 grams of piperacillin sodium and tazobactam sodium, a broad-spectrum combination for severe infections such as sepsis or complicated UTIs. Classified under HTS 3004.10.50.48 due to its specific composition of penicillanic acid derivative with tazobactam, in measured dose for therapeutic IV use. It's commonly used in hospital settings for empiric therapy.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Label with exact strength, lot number, and expiry; ensure GMP certification from manufacturing facility
• Comply with USP <797> standards for sterile compounding if repackaged; declare as pharmaceutical for human use
• Avoid delays by pre-submitting import alerts via FDA's PREDICT system for beta-lactam products